Ronald Silver - 19 Jul 2021 Form 3 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Principal Accounting Officer
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
19 Jul 2021
Net transactions value
$0
Form type
3
Filing time
22 Jul 2021, 16:13:21 UTC
Next filing
22 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IRWD Class A Common Stock 43,242 19 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IRWD Employee Stock Option (Right to Buy) 19 Jul 2021 Class A Common Stock 9,663 $17.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option, granted as a new hire award, vested as to 25% of the shares of Class A Common Stock on June 4, 2019, and 2.08333% of the shares of Class A Common Stock vest each month thereafter for the next 36 months.

Remarks:

Exhibit 24: Power of Attorney